Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
4 hedge funds and large institutions have $18.9M invested in Abeona Therapeutics Inc Warrant in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
267% more capital invested
Capital invested by funds: $5.14M → $18.9M (+$13.7M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$1.66M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$664 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$538 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Soros Fund Management
New York
|
-$851K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $15.8M | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $3M | +$1.66M | +250,000 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| $1K | +$538 | +81 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | +$664 | +100 | New |
|
|
SFM
5
Soros Fund Management
New York
| – | -$851K | -250,000 | Closed |
|
ABEOW Hedge Fund Activity: Q3 2017 in Review
4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q3 2017, worth a combined $18.9M — up 267% from $5.14M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ABEOW positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $1.66M. The largest seller was Soros Fund Management, exiting entirely with an estimated $851K sold.
- 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q3 2017, up from 2 in Q2 2017.
- Funds reported $18.9M of Abeona Therapeutics Inc Warrant stock for Q3 2017, up 267% quarter-over-quarter.
- 3 funds opened new Abeona Therapeutics Inc Warrant positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest Abeona Therapeutics Inc Warrant buyer in Q3 2017 was Highbridge Capital Management, an estimated $1.66M added.
- The largest Abeona Therapeutics Inc Warrant seller in Q3 2017 was Soros Fund Management, an estimated $851K sold.
Based on aggregated 13F filings for Q3 2017.